|
⚲
|
| Keyboard |
| Heberlig Chris
✚
|
|
|---|---|
| CIK # | 0001532217 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001532217] | |
| 4 | [0001532217] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Heberlig Chris | |
| Organovo Holdings Inc | |
| Kiniksa Pharmaceuticals International PLC | |
| Synageva Biopharma Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Organovo Holdings Inc ONVO
Stock Option (Right to Buy) · derivative
|
2020-09-15 | Grant | 20,000 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
|
2019-09-17 | Grant | 50,000 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
|
2019-03-04 | Grant | 46,000 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
|
2018-09-20 | Grant | 45,000 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Class A Common Shares
|
2018-05-29 | Conversion | 6,392 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Series A Preferred Shares · derivative
|
2018-05-29 | Conversion | 74,935 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Series C Preferred Shares · derivative
|
2018-05-29 | Conversion | 6,392 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Class B Common Shares · derivative
|
2018-05-29 | Conversion | 74,935 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Series C Preferred Shares · derivative
|
2018-02-09 | Buy | 6,392 | $15.64 | 99,971 |
|
Synageva Biopharma Corp GEVA
Common Stock
|
2015-06-22 | Grant | 56 | $78.87 | 4,417 |
|
Synageva Biopharma Corp GEVA
Common Stock
|
2015-06-22 | Disposed to issuer | 24,000 | ||
|
Synageva Biopharma Corp GEVA
Common Stock
|
2015-06-22 | Disposed to issuer | 446 | ||
|
Synageva Biopharma Corp GEVA
Stock Options (Right to Buy) · derivative
|
2015-06-22 | Disposed to issuer | 82 | $0.00 | |
|
Synageva Biopharma Corp GEVA
Stock Options (Right to Buy) · derivative
|
2015-06-22 | Disposed to issuer | 838 | $0.00 | |
|
Synageva Biopharma Corp GEVA
Stock Options (Right to Buy) · derivative
|
2015-06-22 | Disposed to issuer | 12,000 | $0.00 | |
|
Synageva Biopharma Corp GEVA
Stock Options (Right to Buy) · derivative
|
2015-06-22 | Disposed to issuer | 12,500 | $0.00 | |
|
Synageva Biopharma Corp GEVA
Stock Options (Right to Buy) · derivative
|
2015-06-22 | Disposed to issuer | 7,500 | $0.00 | |
|
Synageva Biopharma Corp GEVA
Stock Options (Right to Buy) · derivative
|
2015-06-22 | Disposed to issuer | 5,000 | $0.00 | |
|
Synageva Biopharma Corp GEVA
Common Stock
|
2015-06-05 | Grant | 24,000 | $0.00 | |
|
Synageva Biopharma Corp GEVA
Common Stock
|
2015-03-11 | Option exercise | 7,500 | $40.74 | 305,550 |
| showing 20 of 79 most recent transactions | |||||